Drug Overdose Prevention Information

Having trouble viewing this email? View it as a Web page.

PDO email header

May 19, 2020

Here are your weekly opioid epidemic updates from the Indiana State Department of Health:

Indication-Specific Opioid Prescribing for U.S. Patients with Medicaid or Private Insurance, 2017

Despite established knowledge of the potential abuse of prescription opioids, numerous studies have found that prescribing practices remain inconsistent across the country. In this study, data from U.S. administrative insurance claims (including Medicaid and private insurance) was examined to better understand the frequency, dosage, and duration of opioid prescriptions. It was found that opioid prescribing rates were not always consistent with current prescribing guidelines for various conditions and pain levels. This highlights a need for better pain management education and a need to increase patient safety. 

prescription pills

Association of Racial/Ethnic Segregation with Treatment Capacity for Opioid Use Disorder in Counties in the United States

For individuals with opioid use disorder, the current and accepted practice is to treat them with methadone or buprenorphine. However, there is a lack of research into how individual patients may respond better to one medication over the other so both medications should be accessible to all patients so it can be determined which medication works best for them.

In the past, there have been variations in the accessibility of both medications depending on racial/ethnic segregation. In an examination of counties across the United States in 2016, counties that contained clearly segregated Hispanic/Latino and African American communities had more facilities that provided methadone. By comparison, counties with clearly segregated White communities had more facilities that provided buprenorphine. Existing government regulations should take this into consideration when attempting to ensure that both medications are equitable in accessibility.


NIDA Launches Drug Education Booklet Series for Middle School Students

The National Institute on Drug Abuse (NIDA) has released a nine-booklet series that aim at educating middle school students, from grades 5 to 8, on substance abuse. Each of the booklets focus on various drug related topics, each framed from how the brain and body is affected by various drugs. Especially relevant drugs discussed include opioids, nicotine, vaping, and tobacco.

This series comes with a Teacher’s Guide which features evidence-based information and research as well as activities meant to engage students. These booklets and resources can all be downloaded online for free here in English or Spanish. Hard copies of the English booklets can also be ordered for free here.


COVID-19 has streamlined addiction medicine. Will the changes stick?

With the onset of COVID-19, there was worry across the nation that those suffering from opioid addiction would be hindered from receiving the addiction treatment they needed. Early models projected that there could be as many as 75,000 suicides and overdoses as a result of opioid users not receiving treatment due to the pandemic.

However, patients across the United States have reported that since the onset of COVID-19, their addiction treatment has been easier to access. New regulations allow doctors to meet with their patients via video chat or phone call to prescribe methadone or buprenorphine for treatment. This makes care more accessible for many individuals who previously had to find the transportation and time to travel to clinics. Time will tell how effective these new regulations are at providing addiction care to individuals across the United States, but anecdotal evidence points in a positive direction.

addiction treatment

Follow us! @INDTrauma

twitter

Check out our website

world wide web logo

UPCOMING EVENTS

light blue divider

Live Virtual Training: Peer Recovery Supervision

9 a.m.-4:30 p.m. EDT, Thursday May 21-Friday May 22

Indiana Counselor’s Association on Alcohol and Drug Abuse (ICAADA) is offering a two-day virtual training on the importance of ethical and effective supervision for Peer Recovery professionals. This training would be most appropriate for individuals who are currently supervising Peer Recovery Support professionals or have future goals of doing so. This training will be via Zoom, with a cost of $95 for ICAADA members and $160 for non-members. To register for this webinar, click here.

light blue divider

The Americans with Disabilities Act: SUD and Eliminating Barriers to Treatment and Recovery

3:00-4:30 p.m. EDT, Wednesday, May 27th

Many individuals in recovery from addiction are unaware of their civil rights under the Americans with Disabilities Act (ADA). This presentation will provide information on the ADA and how it applies to individuals in treatment for or recovery from substance use disorders (SUDs). The presentation will provide examples of instances when a person is covered under the ADA and how healthcare providers, advocates, attorneys, and others can support their client or patient’s ADA rights.

To register for this webinar, click here.

light blue divider

Effective Treatments for Opioid Use Disorders: Educating & Empowering All Registered Nurses (RN) During an Epidemic

This course examines the epidemiology of opioids in the United States as well as discussing how nurses can better evaluate a patient’s risk for opioid abuse. Risk factors associated with opioid abuse will be discussed and various treatment options that are available. Special attention will also be given to how to work with patients to select an individual care plan that combines medication and psychosocial assisted interventions to meet their health goals.

To register for this webinar, click here.

light blue divider

Your input matters: Follow-up survey on COVID-19 business impacts

From ISMA’s previous COVID-19 Physician Business Impact Survey, it was found that about 50% of members had applied for the Paycheck Protection Program and another 25% were likely to apply to that program or others for coronavirus relief funds. ISMA has asked that you please complete this very brief follow-up survey to help them assess how many practices succeeded in obtaining Covid-19 emergency funding and their plans for the future of their practice. 

To complete the survey, click here.

light blue divider